Inventor · disambiguated record
Cheng-Chou Yu
Also filed as: YU CHENG-CHOU
4 granted patents·7 pending applications·1 citations·filing 2015–2025
56Inventor score
Top patents by PatentIndex Score
11 records- 0179US12091454B2Humanized anti-human neurotensin receptor 1 antibodies and their usesDEV CT BIOTECHNOLOGY·Filed 2022·Granted Sep 17, 2024·1 cites·19 claims
- 0263US2024238432A1Method for glycoprotein modificationHONEYBEAR BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0359US2025197501A1Recombinant antibody, immunoconjugate comprising the same, and uses thereof in treating cancersDEV CT BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 0457US2024209095A1Anti-human pd-l1 antibodies and their usesDEV CT BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 0556US2024197780A1Chimeric antigen receptors, nucleic acids encoding the same, and uses thereof in treating cancersDEV CT BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 0651US12202899B2Anti-human PD-L1 antibodies and their usesDEV CT BIOTECHNOLOGY·Filed 2019·Granted Jan 21, 2025·0 cites·15 claims
- 0750US11998613B2Antibody-drug conjugates containing an anti-mesothelin antibody and uses thereofDEV CT BIOTECHNOLOGY·Filed 2021·Granted Jun 4, 2024·0 cites·15 claims
- 0848US2025381225A1Recombinant antibodies, chimeric antigen receptors, and uses thereof in treating cancersDEV CT BIOTECHNOLOGY·Filed 2025·Application pending·0 cites
- 0944US10138300B2Anti-VEGFR antibody and uses thereofDEV CT BIOTECHNOLOGY·Filed 2017·Granted Nov 27, 2018·0 cites·10 claims
- 1039US2017233480A1Anti-vegfr antibody and uses thereofDEV CT BIOTECHNOLOGY·Filed 2016·Application pending·0 cites
- 1131US2017369525A1Site-specific conjugation through glycoproteins linkage and method thereofDEV CT BIOTECHNOLOGY·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cheng-Chou Yu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →